Document Detail


Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trial.
MedLine Citation:
PMID:  6223819     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
From July 1979 to December 1981, 83 patients from 6 centers in the Lombardy underwent radical nephrectomy for category M0 renal cell carcinoma. Postoperatively they were randomly allocated to adjunctive medroxyprogesterone acetate (MPA) or to a control group. After the first year of follow-up, the relapse rate was 13% in the controls (5 of 38 evaluable patients) versus 28% in the MPA treatment group (9 of 32). Sex steroid receptors were studied in both the tumor and in the surrounding healthy parenchyma by the dextran-coated charcoal technique in 52 of 70 clinically evaluable patients. There was no significant correlation between receptor studies and the relapse rate. Besides, receptors were more often detected in the healthy than in the neoplastic tissue, and values rarely exceeded 10 fmol/mg protein. Due to the negative trend in the MPA treatment group, the admittance of patients to this study was stopped after 120 patients had been accepted.
Authors:
G Pizzocaro; G Di Fronzo; L Piva; R Salvioni; E Ronchi; V Cappelletti; A Giongo; E Mastroberardino; C Cozzoli; E Dormia; S Minervini; A Zanollo; U Fontanella; R Giannoni; A Maggioni; E Lasio
Related Documents :
22500909 - Comparison of postoperative analgesic effect of intrathecal magnesium and fentanyl adde...
22883359 - Effects of folk medicinal plant extract ankaferd blood stopper(®) in vital primary mol...
22672099 - Intraoperative neurophysiologic methods for spinal cord stimulator placement under gene...
22456379 - Clinical outcomes following supraorbital foraminotomy for treatment of frontal migraine...
22866219 - Relationship between intravesical prostatic protrusion and postoperative outcomes in pa...
22870079 - A comparison of two brands of clopidogrel in patients with drug-eluting stent implantat...
12848749 - Development of resistance in pseudomonas aeruginosa obtained from patients with cystic ...
22152629 - An in vitro study comparing the intracanal effectiveness of calcium hydroxide- and lin...
2463609 - Comparison of two myoepicardial pacemaker leads: follow-up in 80 children, adolescents,...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European urology     Volume:  9     ISSN:  0302-2838     ISO Abbreviation:  Eur. Urol.     Publication Date:  1983  
Date Detail:
Created Date:  1983-09-23     Completed Date:  1983-09-23     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7512719     Medline TA:  Eur Urol     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  202-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / drug therapy,  surgery,  therapy*
Adolescent
Adult
Aged
Clinical Trials as Topic
Female
Humans
Kidney Neoplasms / drug therapy,  surgery,  therapy*
Male
Medroxyprogesterone / analogs & derivatives*,  therapeutic use
Medroxyprogesterone Acetate
Middle Aged
Neoplasm Recurrence, Local
Nephrectomy*
Postoperative Period
Prognosis
Prospective Studies
Random Allocation
Receptors, Steroid / analysis
Chemical
Reg. No./Substance:
0/Receptors, Steroid; 520-85-4/Medroxyprogesterone; 71-58-9/Medroxyprogesterone Acetate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Studies on 18F-labeled pyrimidines. Tumor uptakes of 18F-5-fluorouracil, 18F-5-fluorouridine, and 18...
Next Document:  Complete regression of multiple pulmonary metastases in a patient with advanced renal cell carcinoma...